You are here


US increases pressure on UN to ban Harm Reduction

A report published today by the International Narcotics Control Board has highlighted an alarming spread of HIV/AIDS among injecting drug users in Russia, Eastern and Central Europe. An estimated 4 million people are now believed to have been infected in the region, with many more cases expected over the coming year.


HIV+ teens taking more risks

A new study of US HIV+ teenagers has shown that they are taking more risks and having more sexual partners than 10 years ago, probably because the believe that HAART (Highly Active Anti-Retroviral Therapy) stops them being infectious.


South African Death rates jump by 57%

The death rate in South Africa has increased by 57% according to the latest figures released by governmental agency, Statistics SA, with AIDS believed to be a significant factor in the rise, particularly among the 15 to 49 age bracket. Despite tuberculosis being recorded as the primary cause of death in the country, officials have admitted that many of these cases probably became fatal due to an underlying AIDS infection. TB killed 37,917 people aged between 15 and 49 in 2001, while HIV/AIDS reportedly claimed just 7,564.


Nigeria to expand ARV therapy to 100,000 people with AIDS

Nigeria is to dramatically increase the number of people on antiretroviral drugs (ARVs) following a cash boost, the country's health minister said today.

Financial problems mean that only 14,000 of 3.5 million people with HIV are currently on ARV treatment, despite a 2002 initiative to treat people with Indian generic drugs for just 1,000 naira ($7) per patient.


Condoms prove most effective way to cut HIV rates in Uganda

Condoms are the key to the falling rates of HIV in Uganda, according to a study carried out by a group of US and Ugandan AIDS researchers.


GSK acts to stop AIDS drug smuggling

One of the world's largest manufacturers of antiretroviral drugs, GlaxoSmithKline, is to introduce a new initiative to help stop the illegal trade in AIDS drugs.

The company is planning to change the packaging and the colour of all antiretrovirals sent to developing countries in an effort to stop them being smuggled back into Europe for resale at higher prices. It is believed that pharmaceutical companies lose hundreds of millions of dollars every year as a result of drugs being diverted in this way.


UK HIV diagnosis rates remain high

The number of new HIV diagnoses made in the UK in 2004 now stands at 5016, and is expected to rise to around 7000 by the time all late reports are in, according to new figures from the HPA. This compares to figures of 5047 for the same period in 2003. Although the new statistics demonstrate a slight drop in diagnoses made, they do not represent the number of people actually infected during this period, just those who took a test.


New generic drugs factory opens in Gabon

A brand new factory that will manufacture drugs to treat HIV, malaria and TB was opened in Libreville, the capital of Gabon on Saturday.

The factory, which will provide access to treatment for 30 million people currently living in Gabon and five other central African nations, was set up with the help of Brazilian technology and expertise. Brazil began providing free treatment to all HIV+ people in the country several years ago, after the government helped to set up a major generic ARV drugs industry there.